Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Daisuke Ogawa"'
Autor:
Kenichi Shikata, Masakazu Haneda, Toshiharu Ninomiya, Daisuke Koya, Yoshiki Suzuki, Daisuke Suzuki, Hitoshi Ishida, Hiroaki Akai, Yasuhiko Tomino, Takashi Uzu, Motonobu Nishimura, Shiro Maeda, Daisuke Ogawa, Satoshi Miyamoto, Hirofumi Makino, the Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan) collaborative group
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 2, Pp 207-216 (2021)
Abstract Aims/Introduction We evaluated the efficacy of multifactorial intensive treatment (IT) on renal outcomes in patients with type 2 diabetes and advanced‐stage diabetic kidney disease (DKD). Materials and Methods The Diabetic Nephropathy Remi
Externí odkaz:
https://doaj.org/article/008af3b142f74ab5b7527d7cf61aa3eb
Autor:
Kenichi Shikata, Masakazu Haneda, Toshiharu Ninomiya, Daisuke Koya, Yoshiki Suzuki, Daisuke Suzuki, Hitoshi Ishida, Hiroaki Akai, Yasuhiko Tomino, Takashi Uzu, Motonobu Nishimura, Shiro Maeda, Daisuke Ogawa, Satoshi Miyamoto, Hirofumi Makino, the Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan) collaborative group
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 12, Iss 2, Pp 207-216 (2021)
Journal of Diabetes Investigation, Vol 12, Iss 2, Pp 207-216 (2021)
Aims/Introduction We evaluated the efficacy of multifactorial intensive treatment (IT) on renal outcomes in patients with type 2 diabetes and advanced‐stage diabetic kidney disease (DKD). Materials and Methods The Diabetic Nephropathy Remission and
Autor:
Tomoya Nishino, Tadashi Toyama, Takashi Wada, Kenjiro Kimura, Yugo Shibagaki, Hirofumi Makino, Kengo Furuichi, Hiroshi Sato, Daisuke Ogawa, Miho Shimizu, Kentaro Kohagura, Masakazu Haneda, Yoshihiko Ueda, Akinori Hara, Hitoshi Yokoyama, Noriko Uesugi, Yoshifumi Ubara, Hiroshi Kitamura, Seiichi Matsuo, Koki Mise, Yoshiki Suzuki, Satoshi Hisano, Shinichi Nishi, Yukio Yuzawa
Publikováno v:
Nephrology Dialysis Transplantation. 33:138-148
金沢大学医薬保健研究域医学系
Background. The clinical and pathologic manifestations of nephropathy due to type 2 diabetes are diverse, but large-scale pathologic studies with long-termobservations are limited. Methods. Kidney biops
Background. The clinical and pathologic manifestations of nephropathy due to type 2 diabetes are diverse, but large-scale pathologic studies with long-termobservations are limited. Methods. Kidney biops
Autor:
Hideharu Abe, Kenichi Yoshimura, Kiyoshi Mori, Yukie Kurokawa, Hiroyuki Yamauchi, Koshino Y, Masaaki Nakayama, Hitoshi Yokoyama, Sawako Kato, Kei Fukami, Ken-ichi Samejima, Miho Shimizu, Tomohito Gohda, Yukio Yuzawa, Kengo Furuichi, Tadashi Toyama, Takero Naito, Daisuke Nagata, Shoichi Maruyama, Daisuke Koya, Tomoaki Funamoto, Shinji Kitajima, Shouichi Fujimoto, Hidenori Yamazaki, Yoshio Konishi, Takashi Wada, Ikeda K, Masaru Matsui, Daisuke Ogawa, Akinori Hara, Yoshiki Suzuki
Publikováno v:
Clinical and experimental nephrology. 22(2)
There is increased interest in surrogate endpoints for clinical trials of chronic kidney disease. In this nationwide observational study of 456 patients with type 2 diabetes and clinically suspected diabetic nephropathy followed for a median of 4.2 y
Autor:
Koki Mise, Hiroshi Kitamura, Tadashi Toyama, Hirofumi Makino, Yugo Shibagaki, Yoshifumi Ubara, Satoshi Hisano, Hiroshi Sato, Kengo Furuichi, Takashi Wada, Tomoya Nishino, Kentaro Kohagura, Daisuke Ogawa, Yoshiki Suzuki, Miho Shimizu, Hitoshi Yokoyama, Seiichi Matsuo, Shinichi Nishi, Noriko Uesugi, Akinori Hara, Yoshihiko Ueda, Yukio Yuzawa, Junichi Hohino
Publikováno v:
Clinical and experimental nephrology. 22(3)
The Japanese classification of diabetic nephropathy reflects the risks of mortality, cardiovascular events and kidney prognosis and is clinically useful. Furthermore, pathological findings of diabetic nephropathy are useful for predicting prognoses.
Autor:
Hiromi Tachibana, Ikuko Miyazaki, Hirofumi Makino, Hiroshi Yamada, Naoto Terami, Jun Wada, Daisuke Ogawa, Takashi Hatanaka, Norio Sogawa, Masato Asanuma, Jun Eguchi, Atsuko Nakatsuka, Chikage Sato Horiguchi, Kohji Takei
Publikováno v:
American Journal of Physiology-Renal Physiology. 306:F105-F115
Oxidative stress and inflammation play important roles in diabetic complications, including diabetic nephropathy. Metallothionein (MT) is induced in proximal tubular epithelial cells as an antioxidant in the diabetic kidney; however, the role of MT i
Autor:
Haruhito A. Uchida, Tetsuharu Takatsuka, Shinichi Okada, Ryo Kodera, Hitomi Kataoka, Hirofumi Makino, Kyoko Miyasaka, Chikage Sato, Akihiro Funakoshi, Shingo Nishishita, Nobuo Kajitani, Daisuke Ogawa, Motofumi Sasaki, Satoshi Miyamoto, Daisho Hirota, Hisakazu Nishimori, Kenichi Shikata
Publikováno v:
Diabetes
Inflammatory process is involved in the pathogenesis of diabetic nephropathy. In this article, we show that cholecystokinin (CCK) is expressed in the kidney and exerts renoprotective effects through its anti-inflammatory actions. DNA microarray showe
Autor:
Ryo Kodera, Jun Eguchi, Hiromi Tachibana, Chikage Sato-Horiguchi, Kenichi Shikata, Daisuke Ogawa, Jun Wada, Naoto Terami, Atsuko Nakatsuka, Hirofumi Makino
Publikováno v:
Nephron Experimental Nephrology. 121:e97-e108
Background/Aims: Telmisartan, an angiotensin II type 1 receptor blocker, is widely used to treat hypertension and kidney diseases, including diabetic nephropathy, because of its renoprotective effects. However, the mechanism by which telmisartan prev
Autor:
Daisuke Ogawa, Kenichi Shikata, Hirofumi Makino, Takuya Kitamura, Tatsuaki Nakatou, Nobuo Kajitani, Akihiko Nakamura
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Recent studies have pointed to the effectiveness of combination therapy with an angiotensin-converting-enzyme inhibitor (ACEI) and an angiotensin receptor blocker (ARB) for diabetic nephropathy. However, some controversy over this c
Autor:
Takashi Hatanaka, Jun Wada, Hiromi Tachibana, Jun Eguchi, Kohji Takei, Daisuke Ogawa, Hiroshi Yamada, Hirofumi Makino, Tatsuyuki Inoue
Publikováno v:
Pharmacology Research & Perspectives
It is unclear whether the improvement in diabetic nephropathy by sodium glucose cotransporter 2 (SGLT2) inhibitors is caused by a direct effect on SGLT2 or by the improvement in hyperglycemia. Here, we investigated the effect of dapagliflozin on earl